(MedPage Today) — PHOENIX — An implantable autologous cell therapy led to higher remission rates compared with standard surgical care in patients with persistent Crohn’s perianal fistulas who had failed prior treatments, the randomized phase…
Source link : https://www.medpagetoday.com/meetingcoverage/acg/118262
Author :
Publish date : 2025-10-31 18:21:00
Copyright for syndicated content belongs to the linked Source.
